The Procter & Gamble Company provided earnings guidance for the full fiscal year 2023. For the fiscal year 2023, the company expects fiscal year 2023 all-in sales growth in the range of in-line to up 2% versus the prior fiscal year. The Company expects organic sales growth in the range of 3% to 5%.

The company expects fiscal 2023 diluted net earnings per share growth in the range of in-line to up 4% versus fiscal 2022 EPS of $5.81. At the mid-point of the range, this outlook equates to $5.93 per share, or an increase of 2%.